本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Avidity Biosciences, Inc.

32.66
-3.5800-9.88%
盘后33.671.01+3.09%16:34 EDT
成交量:482.67万
成交额:1.60亿
市值:39.37亿
市盈率:-10.79
高:38.00
开:38.00
低:31.59
收:36.24
数据加载中...
2024/11/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/08

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/08

重要事件披露

Form 8-K - Current report
2024/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/30

重要事件披露

Form 8-K - Current report
2024/10/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/03

重要事件披露

Form 8-K - Current report
2024/10/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/23

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/15

重要事件披露

Form 8-K - Current report
2024/08/09

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/09

重要事件披露

Form 8-K - Current report